Advertisement

Conquer Cancer Foundation


November 10, 2018

Advertisement
Get Permission

Advertisement

Advertisement



Apr
10
Today In Oncology
Pre–Salvage Radiotherapy PSA Levels and Outcomes With Long-Term Antiandrogen Therapy in Prostate Cancer
Cancer Care in the Time of COVID-19 Statement From Fox Chase Cancer Center
Trastuzumab Beyond Progression in HER2-Positive Advanced Gastric/Gastroesophageal Junction Cancer
Apixaban for Cancer-Associated VTE
FDA Pipeline Approval of New Dosing for Biosimilar, Plus Two Fast Track Designations
View More 
Advertisement
Most Read Stories
Oncologists on the Front Lines of the COVID-19 Pandemic: A Conversation With Miriam A. Knoll, MD
FDA Approves Encorafenib/Cetuximab for BRAF V600E–Mutated Metastatic Colorectal Cancer
Stereotactic Ablative Radiation vs Observation in Oligometastatic Prostate Cancer: ORIOLE Trial
Harvard Medical Student’s Innovation: Disinfection You Can See
Case Study: Patient With Multiple Myeloma Treated for COVID-19 With Tocilizumab
View More 
Most Viewed Videos
Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy
Neeraj Agarwal, MD, on Castration-Resistant Prostate Cancer: Results From the COSMIC-021 Study of Cabozantinib and Atezolizumab
Martin McCarter, MD, on Refinement of Surgical Treatment: Expert Perspective on ASCO’s 2020 Advance of the Year
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
Kathleen N. Moore, MD, on Ovarian Cancer: Results From the QUADRA Study
View More 
© 2020 HSP News Service, L.L.C.